These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3637066)

  • 1. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.
    Frongillo RF; Donati L; Federico G; Martino P; Moroni M; Ortona L; Palumbo M; Pasticci BM; Pizzigallo E; Privitera G
    Antimicrob Agents Chemother; 1986 May; 29(5):789-96. PubMed ID: 3637066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.
    Coppens L; Hanson B; Klastersky J
    Antimicrob Agents Chemother; 1983 Jan; 23(1):36-41. PubMed ID: 6550482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program.
    Holley JL; Bernardini J; Johnston JR; Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):142-6. PubMed ID: 2382651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections.
    Hirschl A; Stanek G; Rotter M
    J Antimicrob Chemother; 1984 May; 13(5):429-35. PubMed ID: 6735962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE; Cornere BM; MacCulloch D
    Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase.
    John JF; McNeill WF
    Antimicrob Agents Chemother; 1980 Feb; 17(2):179-83. PubMed ID: 6966906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.
    Varaldo PE; Cipriani P; Focá A; Geraci C; Giordano A; Madeddu MA; Orsi A; Pompei R; Prenna M; Repetto A
    J Clin Microbiol; 1984 Jun; 19(6):838-43. PubMed ID: 6565709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
    Frongillo RF; Bianchi P; Moretti A; Pasticci MB; Ripa S; Pauluzzi S
    Antimicrob Agents Chemother; 1984 May; 25(5):666-8. PubMed ID: 6563877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of methicillin-resistant coagulase-negative staphylococci from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and comparison of different molecular techniques for discriminating isolates of Staphylococcus epidermidis.
    de Mattos EM; Teixeira LA; Alves VM; Rezenda e Resende CA; da Silva Coimbra MV; da Silva-Carvalho MC; Ferreira-Carvalho BT; Figueiredo AM
    Diagn Microbiol Infect Dis; 2003 Jan; 45(1):13-22. PubMed ID: 12573546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does nasal cocolonization by methicillin-resistant coagulase-negative staphylococci and methicillin-susceptible Staphylococcus aureus strains occur frequently enough to represent a risk of false-positive methicillin-resistant S. aureus determinations by molecular methods?
    Becker K; Pagnier I; Schuhen B; Wenzelburger F; Friedrich AW; Kipp F; Peters G; von Eiff C
    J Clin Microbiol; 2006 Jan; 44(1):229-31. PubMed ID: 16390977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of microbiologic characteristics of pathogenic and saprophytic coagulase-negative staphylococci from patients on continuous ambulatory peritoneal dialysis.
    Baddour LM; Smalley DL; Kraus AP; Lamoreaux WJ; Christensen GD
    Diagn Microbiol Infect Dis; 1986 Sep; 5(3):197-205. PubMed ID: 3638993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and characteristics of coagulase-negative, methicillin-resistant staphylococci.
    Wilkinson BJ; Maxwell S; Schaus SM
    J Clin Microbiol; 1980 Aug; 12(2):161-6. PubMed ID: 6971871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin resistance and biofilm production in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus in México.
    García A; Martínez C; Juárez RI; Téllez R; Paredes MA; Herrera MDR; Giono S
    Biomedica; 2019 Sep; 39(3):513-523. PubMed ID: 31584765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis.
    Gruer LD; Bartlett R; Ayliffe GA
    J Antimicrob Chemother; 1984 Jun; 13(6):577-83. PubMed ID: 6332107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin in infections caused by methicillin-resistant staphylococci.
    Drabu YJ; Walsh B; Blakemore PH; Mehtar S
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():89-92. PubMed ID: 2965136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Que YA; Entenza JM; Francioli P; Moreillon P
    J Infect Dis; 1998 Jan; 177(1):146-54. PubMed ID: 9419181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
    Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
    Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.